Cablivi “Now Approved” Web Page Feb 13, 2019Feb 10, 2019 Brand: Cablivi (caplacizumab-yhdp), Injection Parent Company: Sanofi Genzyme Drug Type: Prescription Drug Category: Hematology Campaign: now-approved Targeting: HCPs Patient Website: https://www.cablivi.com/ HCP Website: ‘Now Approved’ Message Mobile